Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
For full access to this article login to GEN Select now.
Protein Microarrays See Broader Utilization
Recent Improvements Have Made the Technology More Consistent and Accurate
- Protein microarrays are one aspect of highly automated, large-scale biological screening technologies, the other is nucleic acid arrays. As DNA arrays reveal their origin in Southern blotting protocols, protein microarrays reflect their genesis in Western blotting, in which protein mixtures are separated on acrylamide gels, transferred to nitrocellulose, and ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.